Navigation Links
Springer to publish Journal of NeuroVirology
Date:7/19/2010

Starting in January 2011, Springer will publish the Journal of NeuroVirology (JNV), a bi-monthly publication closely affiliated with the International Society for NeuroVirology. Previously published by Taylor & Francis/Informa, the five-year contract with Springer runs to 2015.

The Journal of NeuroVirology publishes high-quality basic science and clinical studies on the molecular biology and pathogenesis of viral infections of the nervous system, and reports on the development of novel therapeutic strategies using neurotropic viral vectors. The journal also focuses on articles covering non-viral infections that affect the central nervous system. Original research articles, reviews, case reports and coverage of scientific meetings are included. The editor-in-chief is Professor Kamel Khalili, Chair of the Department of Neuroscience at Temple University School of Medicine in Philadelphia, USA.

Ann Avouris, Senior Editor of Neuroscience at Springer, said, "The journal brings additional content for Springer's neuroscience portfolio in an area that is currently not covered. The subject is growing in interest, with new studies being published on neuroAIDS, viruses and neurodegeneration, and transmissible encephalopathies. Springer will be able to help grow the society, and support them in accomplishing their mission."

Professor Khalili said, "Since its inception in 1995, JNV has provided a unique platform for cross communication between basic scientists and clinican researchers studying viral disorders of the nervous system. We're excited about our new partnership and will work closely with Springer to continue advancing the field of neurovirology and infections of the nervous system as a whole."


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1

Related biology news :

1. Springer editorial board member receives Humboldt Research Award
2. Springer to partner with the Gesellschaft für Biologische Systematik
3. Springer signs publishing agreement with ISOBM
4. International Biometric Society co-publishes journal with Springer
5. Springer signs agreement with British Society of Research on Ageing
6. Biomedical Engineering Societys new journal to be published by Springer
7. Editor of Springer classic human genetics reference receives prize
8. Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences
9. Springer and the American College of Medical Toxicology to work together
10. Springer launches new journal Food Digestion
11. Springer to publish Symbiosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: